insights_auto
Kāpēc uzņēmuma NOVOB80 akciju cena ir pieaugusi 2,33%?
Atklājiet vairāk iespējuchevron_right
NOVOB80:BKK
NOVOB80 KTB DR
1,32 ฿
arrow_upward
+2,33%(+0,030) 1 d.
16. okt., 02:55:30 GMT+7 · THB
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: NOVOB80…
Atvērt
1,28 ฿
Augsta
1,30 ฿
Zema
1,27 ฿
Tirgus kapitalizācija
132,00 mljrd.
Vid. apjoms
3,88 milj.
Apjoms
4,35 milj.
Augstākā 52 ned.
2,02 ฿
Zemākā 52 ned.
1,12 ฿
Apgrozībā esošās akcijas
3,00 mljrd.
Darbinieku skaits
67 tūkst.
Atvērt
1,28 ฿
Augsta
1,30 ฿
Zema
1,27 ฿
Tirgus kapitalizācija
132,00 mljrd.
Vid. apjoms
3,88 milj.
Apjoms
4,35 milj.
Augstākā 52 ned.
2,02 ฿
Zemākā 52 ned.
1,12 ฿
Apgrozībā esošās akcijas
3,00 mljrd.
Darbinieku skaits
67 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
The Motley Fool
·
pirms 16 stundām
Novo Nordisk and Eli Lilly Just Got Some Fantastic News
TradingKey
·
pirms 1 dienas
Novo Nordisk A/S Stock (NVO) Moved Up by 3.38% on Oct 15: What Investors Need To Know
Traders Union
·
pirms 1 dienas
Why is Novo Nordisk stock up 3.2% today?
Traders Union
·
pirms 2 dienām
Novo Nordisk stock consolidates amid seller pressure near $38.39 resistance
Profils
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark, and it became the highest valued company in Europe. Wikipedia
Par “NOVOB80 KTB DR”
ĢenerāldirektorsMaziar Mike Doustdar
Darbinieki66,7 tūkst.
Dibināšanas datums1923
Galvenais birojsBagsværd, Galvaspilsētas reģions, Dānija
Sektors-
Tīmekļa vietnenovonordisk.com